UNSPSC 51101613: Pentamidine

This classification denotes an antiprotozoal agent and antifungal with the molecular formula C19H24N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 673LC5J4LQ, chemically known as 4,4-(pentamethylenedioxy)dibenzamidine but generally known as pentamidine, which bears US NIH Compound Identifier 4735. European Medicines Agency schedules Pentamidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09682MIG. The term PENTAMIDINE is an International Non-Proprietary Name.

UNSPSC 51101613 Pentamidine, a Commodity code, does not map to the pharmaceutical and medical supply procurement activity actually appearing in recent state and local solicitations. The code nominally identifies a specific antimicrobial agent, but recent opportunities under this code bracket show state and local governments procuring broad medical and first aid supplies, generic pharmaceuticals, over-the-counter products, and naloxone-based emergency response systems through cooperative purchasing agreements and direct competitive bidding.

State and local issuing bodies soliciting under this code span city purchasing departments, county health and emergency services divisions, state health agencies, and multistate cooperative purchasing alliances. The City of Tampa's Purchasing Department solicited 169 line items of medical and emergency supplies for the Tampa Fire Department Rescue Division through sealed bidding; Seminole County, Florida issued an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually; the Texas Health and Human Services Commission issued an RFI to gather vendor capabilities for direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP to establish multiple-award contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon. The Tampa procurement is sheltered exclusively for certified Small Local Business Enterprises with a 5% bid discount up to $10,000 and carries an estimated contract value of $700,000. The MMCAP RFP, with a proposal deadline of March 26, 2026, weights price competitiveness at 75% and requires vendors to maintain relationships with authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC, with products effective July 1, 2026.

Recent activity concentrates in Florida and Minnesota, with secondary activity in Texas and Oregon. The mismatch between the code's nominal scope—pentamidine as a single pharmaceutical agent—and the actual procurement landscape suggests that state and local offices may be using this code as a catch-all for diverse pharmaceutical and emergency medical supply categories rather than limiting procurement to pentamidine specifically. Firms pursuing this code should expect to compete across broad medical supply categories, generic pharmaceuticals, and emergency response products rather than a single-product market.